Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
1,444 results
  1. Methods - Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - .... 
    https://www.ncbi.nlm.nih.gov/books/NBK84293
    ... TIMI-3 blood flow, ejection fraction, distal embolization, MACE), mortality, safety (coronary dissection, coronary perforation, prolonged procedure time), or ...
  2. Outcome Definition and Measurement - Developing a Protocol for Observational Comparative Effectiveness Research: A ... 
    https://www.ncbi.nlm.nih.gov/books/NBK126186
    ... coronary intervention or PCI). The varying definitions of MACE included one related to safety only [composite of death, MI, and stent thrombosis ( ... MI were at greater risk of 1-year MACE. However, for the composite of safety and effectiveness endpoints, the risk of 1-year ...
  3. NLM Digital Collections - Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
    resource.nlm.nih.gov/9918680387906676
    ... for PCSK9 inhibitors. However, long-term data on MACE and safety are lacking, and thus there remains some uncertainty ... short-term biochemical outcomes; long-term data on MACE and safety are lacking. One important controversy is whether the ...
  4. NLM Digital Collections - Hospital literature index (Volume 24) 
    resource.nlm.nih.gov/7807587X11
    ... 150-4 D 67 Riot About face for Mace. Nat Safety News 98: 66-8 O 68 "Chemical Mace" ... See also: Breakage and theft) About face for Mace. Nat Safety News 98: 66-8 O 68 Admitting staff ...
  5. NLM Digital Collections - Cumulative index of hospital literature (1965-1969) 
    resource.nlm.nih.gov/60120460RX5
    ... 353-4 N 69 Riot About face for Mace. Nat Safety News 98: 66-8 O 68 American Hospital ... Breakage and theft: Key control) About face for Mace. Nat Safety News 98: 66-8 O 68 Admitting staff ...
  6. NLM Digital Collections - M64-4 - Testimony - Dr. Sidney Wolfe (1973) 
    https://resource.nlm.nih.gov/2934097RX338
    ... MEDICAL DEVICES. Despite repeate d claims for its safety mace by its inventor, “Lne super Coil -has never been properly tested according to several exverts in the abortion field, and there are no published reports documenting its safety in the medical literature. According to one gynecologist, ...
  7. How this guideline was developed - Medicines Optimisation - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK355914
    ... for exclusion: Not relevant Barata IA, Benjamin LS , Mace SE , et al. (2007) Pediatric patient safety in the prehospital/emergency department setting. Pediatric Emergency ...
  8. NLM Digital Collections - Tirzepatide for type 2 diabetes : final report 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022
    resource.nlm.nih.gov/9918506286606676
    ... ratio point estimate as injectable semaglutide for composite MACE and no adjustment to other outcomes to reflect tirzepatide's cardiovascular safety study. The scenario analysis that includes tirzepatide's changes ...
  9. Detailed Methods - Screening for Asymptomatic Carotid Artery Stenosis in the General Population: An Evidence Update for ... 
    https://www.ncbi.nlm.nih.gov/books/NBK567815
    ... ti,ab. (761472) side effect$.ti,ab. (211943) safety.ti,ab. (405799) postoperative event$.ti,ab. (608) Risk factors/ or Risk assessment/ (985343) risk$.ti. (412304) (MACEs or myocardial infarction or arrhythmia or ipsilateral stroke ...
  10. NLM Digital Collections - Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis : ... 
    Publication: Boston, MA : Institute for Clinical and Economic Review, December 2 2016
    resource.nlm.nih.gov/101704696
    ... of these events than other drugs. Long-term safety data on all-cause mortality, MACE, malignancy, and serious infections are available for TNF-α agents and ustekinumab but not for the other drugs of interest for this ... on other safety concerns among the biologic agents or in comparison ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last